Personalised therapy in inflammatory bowel disease.

Area of Science:

• Gastroenterology and Immunology
• Pharmacology and Therapeutics

Background:

• Inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn's disease, present diverse phenotypes impacting patient quality of life.
• Recent advancements include biological therapies and novel small molecules revolutionizing IBD management.
• The availability of multiple treatment options necessitates personalized approaches to optimize patient care.

Purpose of the Study:

• To review and present personalized therapeutic strategies for managing inflammatory bowel diseases.
• To guide the selection and timing of medications for individual IBD patients.
• To enhance the quality of life for patients with ulcerative colitis and Crohn's disease.

Main Methods:

• Literature review of recent advancements in IBD pharmacotherapy.
• Analysis of therapeutic options based on disease phenotype and patient characteristics.
• Synthesis of evidence supporting personalized treatment algorithms.

Main Results:

• Identification of key factors influencing treatment response in IBD.
• Overview of current and emerging therapeutic agents and their mechanisms of action.
• Framework for tailoring medication choice and initiation speed.

Conclusions:

• Personalized therapeutic approaches are essential for effective IBD management.
• Optimizing medication selection and timing can significantly improve patient outcomes and quality of life.
• This review provides a foundation for individualized treatment strategies in ulcerative colitis and Crohn's disease.